3/23
04:43 pm
nvs
Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree [Seeking Alpha]
Low
Report
Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree [Seeking Alpha]
3/23
07:40 am
nvs
Is iShares International Equity Factor ETF (INTF) a Strong ETF Right Now? [Yahoo! Finance]
Low
Report
Is iShares International Equity Factor ETF (INTF) a Strong ETF Right Now? [Yahoo! Finance]
3/23
02:32 am
nvs
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026 [Yahoo! Finance]
Low
Report
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026 [Yahoo! Finance]
3/21
07:13 am
nvs
Novartis (NVS) was upgraded by Sanford C. Bernstein to "hold".
Low
Report
Novartis (NVS) was upgraded by Sanford C. Bernstein to "hold".
3/20
04:47 pm
nvs
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset [Yahoo! Finance]
Low
Report
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset [Yahoo! Finance]
3/20
07:37 am
nvs
Novartis to acquire SNV4818 from Synnovation [Yahoo! Finance]
Low
Report
Novartis to acquire SNV4818 from Synnovation [Yahoo! Finance]
3/20
06:58 am
nvs
Novartis to buy experimental breast cancer drug in up to $3 billion deal [Yahoo! Finance]
Low
Report
Novartis to buy experimental breast cancer drug in up to $3 billion deal [Yahoo! Finance]
3/20
04:52 am
nvs
Novartis to buy experimental breast cancer drug in up to $3 billion deal [Yahoo! Finance Canada]
Low
Report
Novartis to buy experimental breast cancer drug in up to $3 billion deal [Yahoo! Finance Canada]
3/20
02:54 am
nvs
Novartis agrees to acquire a pan-mutant-selective PI3Ka inhibitor, strengthening its breast cancer pipeline [Yahoo! Finance]
Low
Report
Novartis agrees to acquire a pan-mutant-selective PI3Ka inhibitor, strengthening its breast cancer pipeline [Yahoo! Finance]
3/20
02:36 am
nvs
Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Ka Inhibitor Program [Yahoo! Finance]
Low
Report
Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Ka Inhibitor Program [Yahoo! Finance]
3/17
09:11 pm
nvs
????·????????????????2036??7?3,563??????????-2026?~2036??CAGR 4.98%??? [CNET News]
Medium
Report
????·????????????????2036??7?3,563??????????-2026?~2036??CAGR 4.98%??? [CNET News]
3/17
07:12 pm
nvs
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy [Yahoo! Finance]
Medium
Report
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy [Yahoo! Finance]
3/16
06:41 am
nvs
Novartis unveils new share buyback program [Seeking Alpha]
Low
Report
Novartis unveils new share buyback program [Seeking Alpha]
3/13
08:13 pm
nvs
Novartis AGM Links Board Refresh And Dividend Growth To Future Returns [Yahoo! Finance]
Low
Report
Novartis AGM Links Board Refresh And Dividend Growth To Future Returns [Yahoo! Finance]
3/13
02:01 pm
nvs
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa [Yahoo! Finance]
Low
Report
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa [Yahoo! Finance]
3/13
09:29 am
nvs
Peanut Allergy Market Analysis Report 2025-2035: PALFORZIA and Xolair Approvals, Improved Diagnosis and Innovative Drug Delivery Platforms Drive Growth [Yahoo! Finance]
Low
Report
Peanut Allergy Market Analysis Report 2025-2035: PALFORZIA and Xolair Approvals, Improved Diagnosis and Innovative Drug Delivery Platforms Drive Growth [Yahoo! Finance]
3/11
08:04 pm
nvs
Lilly unveils $3 billion production expansion in China [Yahoo! Finance]
Low
Report
Lilly unveils $3 billion production expansion in China [Yahoo! Finance]
3/11
08:42 am
nvs
Novartis (NVS) was upgraded by Argus from "hold" to "buy". They now have a $180.00 price target on the stock.
Low
Report
Novartis (NVS) was upgraded by Argus from "hold" to "buy". They now have a $180.00 price target on the stock.
3/10
12:01 pm
nvs
Sandoz creates biosimilar unit to benefit from major patent cliff [Seeking Alpha]
Low
Report
Sandoz creates biosimilar unit to benefit from major patent cliff [Seeking Alpha]
3/10
09:45 am
nvs
Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board [Yahoo! Finance]
Low
Report
Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board [Yahoo! Finance]
3/7
07:03 pm
nvs
Novartis Advances Immunology And Oncology Plans As Valuation Gap Persists [Yahoo! Finance]
Low
Report
Novartis Advances Immunology And Oncology Plans As Valuation Gap Persists [Yahoo! Finance]
3/6
02:48 pm
nvs
Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
Low
Report
Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
3/6
10:53 am
nvs
Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push [Yahoo! Finance]
Low
Report
Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push [Yahoo! Finance]
3/6
08:51 am
nvs
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting [Yahoo! Finance]
Low
Report
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting [Yahoo! Finance]
3/3
03:09 pm
nvs
Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc. [Yahoo! Finance]
Low
Report
Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc. [Yahoo! Finance]